INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.410
-0.010 (-0.70%)
At close: May 29, 2026, 4:00 PM EDT
1.409
-0.001 (-0.11%)
After-hours: May 29, 2026, 7:31 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $37.49 million as of May 29, 2026. Its market cap has decreased by -79.96% in one year.
Market Cap
37.49M
Enterprise Value
17.64M
1-Year Change
-79.96%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $37.49M, a decrease of -51.83%. That is a compound annual growth rate of -9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 37.75M | -8.97% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 41.39M |
| NanoViricides | 39.87M |
| Veru Inc. | 37.40M |
| Lantern Pharma | 37.10M |
| Actinium Pharmaceuticals | 36.79M |
| Grace Therapeutics | 36.05M |
| ABVC BioPharma | 35.13M |
| Daré Bioscience | 34.90M |